Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial In this phase III trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback